坦洛新联合爱普列特治疗良性前列腺增生症的临床观察

摘要

Objective To investigate tamsulosin combination treatment of benign prostatic hyperplasia epristeride ef ectiveness and safety. Methods A retrospective analysis of 218 cases of patients with BPH urology, including the control group 75 patients given tamsulosin release capsules; patients treated with 143 cases in the control group based on the use epristeride films, and recorded two symptoms changing circumstances and adverse reactions. Results Three months later two groups of patients symptoms improved significantly in the treatment group to improve the condition of the indicators are bet er than the control group, there were significant difference statistical y significant. Conclusion Tamsulosin alone treatment of benign prostatic hyperplasia safe and effective, tamsulosin combination therapy with epristeride can quickly relieve symptoms, the clinical ef ect will be more obvious.%目的探讨坦洛新联合爱普列特治疗良性前列腺增生症的有效性及安全性。方法回顾性分析泌尿科BPH患者218例，其中对照组患者75例，给予坦洛新缓释胶囊；治疗组患者143例在对照组基础上加用爱普列特片，并记录两组患者症状改变情况及不良反应。结果3个月后两组患者症状改善明显，治疗组病情改善各项指标均优于对照组两组差异显著具有统计学意义。结论单用坦洛新治疗良性前列腺增生症安全有效，坦洛新与爱普列特联合用药可以迅速缓解症状，临床效果将更加明显。